Margaret Wallen

Margaret Wallen

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
MWMargaret Wallen
Margaret Wallen
SOStephen J. O’fLaherty
Stephen J. O’fLaherty
MWMary-Clare A. Waugh
Mary-Clare A. Waugh

20 January 2010 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
BHBrian Hoare
Brian Hoare
MWMargaret Wallen
Margaret Wallen
CIChristine Imms
Christine Imms
EVElmer Villanueva
Elmer Villanueva
HRHyam Barry Rawicki
Hyam Barry Rawicki
LCLeeanne Carey
Leeanne Carey

16 September 2011 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
MWMargaret Wallen
Margaret Wallen
JZJenny Ziviani
Jenny Ziviani
ONOlivia Naylor
Olivia Naylor
RERuth Evans
Ruth Evans
INIona Novak
Iona Novak
RHRobert D Herbert
Robert D Herbert
Aim Conventional constraint‐based therapies are intensive and demanding to implement, particularly for children. Modified forms of constraint‐based therapies that are family‐centred may be more acceptable and feasible for families of children with cerebral palsy (CP)‐but require rigorous evaluation using randomized trials. The aim of this study was to determine the effects of modified constraint‐induced therapy compared with intensive occupational therapy on activities of daily living and upper limb outcomes in children with hemiplegic CP. Method In this assessor‐blinded pragmatic randomized trial, 50 children (27 males, 23 females; age range 19mo–7y 10mo) with hemiplegic CP were randomized using a concealed allocation procedure to one of two 8‐week interventions: intensive occupational therapy (n=25), or modified constraint‐induced therapy (n=25). Manual Ability Classification System (MACS) levels of the participants were, level I n=2, II n=37, III n=8, and level IV n=1; Gross Motor Function Classification System (GMFCS) levels were, level I n=33, level II n=15, and level III n=1. Participants were recruited through three specialist CP centres in Australia and randomized between January 2008 and April 2010. Children randomized to modified constraint‐induced therapy wore a mitt on the unaffected hand for 2 hours each day, during which time the children participated in targeted therapy. The primary outcome was the Canadian Occupational Performance Measure (COPM – measured on a 10‐point scale) at completion of therapy. Other outcome measures were Goal Attainment Scaling, Assisting Hand Assessment, Pediatric Motor Activity Log, Modified Ashworth Scale, Modified Tardieu Scale, and a parent questionnaire. Assessments were carried out at 10 weeks and 6 months following randomization. Results All participants were included in the analysis. Between‐group differences for all outcomes were neither clinically important nor statistically significant. The mean difference in COPM was 0.3 (95% confidence interval [CI] −0.8 to 1.4; p=0.61) and mean difference in COPM satisfaction was 0.1 (95% CI −1.1 to 1.2; p=0.90). Minor adverse events were reported by five of the 25 participants in the modified constraint‐induced therapy group and by one of the 25 in the intensive occupational therapy group. All adverse events were related to participants’ lack of acceptance of therapy. Interpretation Modified constraint‐induced therapy is no more effective than intensive occupational therapy for improving completion of activities of daily living or upper limb function in children with hemiplegic CP.

1 February 2004 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
PDF file
MWMargaret Wallen
Margaret Wallen
SOStephen J O’flaherty
Stephen J O’flaherty
MWMary-Clare A Waugh
Mary-Clare A Waugh

18 September 2017 in BMJ Open
Verified
Journal Article
Open access
PDF file
RBRoslyn Boyd
Roslyn Boyd
JZJenny Ziviani
Jenny Ziviani
LSLeanne Nott Sakzewski
Leanne Nott Sakzewski
INIona Novak
Iona Novak
NBNadia Badawi
Nadia Badawi
SRStephen Rose
Stephen Rose
Objectives Congenital hemiplegia is the most common form of cerebral palsy (CP). Children with unilateral CP show signs of upper limb asymmetry by 8 months corrected age (ca) but are frequently not referred to therapy until after 12 months ca. This study compares the efficacy of infant-friendly modified constraint-induced movement therapy (Baby mCIMT) to infant friendly bimanual therapy (Baby BIM) on upper limb, cognitive and neuroplasticity outcomes in a multisite randomised comparison trial. Methods and analysis 150 infants (75 in each group), aged between 3 and 6 months ca, with asymmetric brain injury and clinical signs of upper extremity asymmetry will be recruited. Children will be randomised centrally to receive equal doses of either Baby mCIMT or Baby BIM. Baby mCIMT comprises restraint of the unimpaired hand using a simple restraint (eg, glove, sock), combined with intensive parent implemented practice focusing on active use of the impaired hand in a play-based context. In contrast, Baby BIM promotes active play requiring both hands in a play-based context. Both interventions will be delivered by parents at home with monthly home visits and interim telecommunication support by study therapists. Assessments will be conducted at study entry; at 6, 12 months ca immediately postintervention (primary outcome) and 24 months ca (retention). The primary outcome will be the Mini-Assisting Hand Assessment. Secondary outcomes include the Bayley Scale for Infant and Toddler Development (cognitive and motor domains) and the Hand Assessment of Infants. A subset of children will undertake MRI scans at 24 months ca to evaluate brain lesion severity and brain (re)organisation after intervention. Ethics and dissemination Full ethical approvals for this study have been obtained from the relevant sites. The findings will be disseminated in peer-reviewed publications. Trial registration number Australian and New Zealand Clinical Trials Registry: ACTRN12615000180516, Pre results.

29 September 2017 in Developmental Neurorehabilitation
Verified
Journal Article
Closed access
PKPetra Karlsson
Petra Karlsson
AAAbigail Allsop
Abigail Allsop
BDBetty-Jean Maria Dee-Price
Betty-Jean Maria Dee-Price
MWMargaret Wallen
Margaret Wallen
The primary objective of this systematic review was to examine the effectiveness of eye-gaze control technology for facilitating communication across different social contexts for people with cerebral palsy and significant physical disability. Systematic review. The search identified 756 potentially eligible articles, of which two, low level articles were eligible. One study reported positive results for achieving communication goals for children with cerebral palsy. The second concluded that eye-gaze control technology resulted in greater quality of life and less depression for adults with late stage amyotrophic lateral sclerosis when compared to non-users. Research regarding the effectiveness of eye-gaze control technology used to access a laptop, tablet or computer on communication outcomes, participation, quality of life and self-esteem in children, adolescents and adults with cerebral palsy and significant physical disability is sparse. A scoping review to fully identify issues to inform clinical practice and future research is required.